Goldman Sachs Forecasts Strong Price Appreciation for Calumet Stock

Analysts raise price target for the oil and gas company's shares

Mar. 14, 2026 at 8:10am

Got story updates? Submit your updates here. ›

Calumet (NASDAQ:CLMT), an independent provider of specialty products derived from petroleum and renewable feedstocks, had its price target raised from $24 to $34 by research analysts at The Goldman Sachs Group. The firm maintained a 'buy' rating on the stock, indicating a potential upside of 18.92% from the previous close.

Why it matters

This positive outlook from a major investment bank suggests that Calumet's business model and product portfolio are seen as attractive by Wall Street, potentially signaling growth opportunities for the company in the coming years.

The details

The Goldman Sachs Group cited Calumet's integrated network of manufacturing plants, blending terminals, and storage facilities across North America as well as its ability to deliver customized products and technical services to industrial, automotive, consumer, and agricultural end markets as factors contributing to the price target increase.

  • The research note was issued on Thursday, March 14, 2026.

The players

The Goldman Sachs Group

A multinational investment bank and financial services company.

Calumet (NASDAQ:CLMT)

An independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks.

Got photos? Submit your photos here. ›

The takeaway

This positive outlook from a major investment bank suggests that Calumet's diversified product portfolio and integrated business model are seen as attractive growth opportunities, potentially signaling a bright future for the company.